Measuring the impact of new technology: An outcomes-based approach

被引:13
作者
Sachdeva, RC
机构
[1] Med Coll Wisconsin, Crit Care Sect, Dept Pediat, Milwaukee, WI 53201 USA
[2] Med Coll Wisconsin, Crit Care Sect, Dept Epidemiol, Milwaukee, WI 53201 USA
[3] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
关键词
technology; technology assessment; technology evaluation; outcomes; value assessment; investment models; capital decision-making; information technology;
D O I
10.1097/00003246-200108001-00008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In the current era of decreasing resources, many healthcare organizations are under increasing pressure to evaluate new technology. Advances and innovations in healthcare technology are instrumental in reshaping the healthcare system and in impacting the practice of medicine, including critical care. Healthcare organizations are faced with the following four questions related to adopting a new technology: 1) Should the organization invest in this technology? 2) What are the associated benefits and risks of the capital investment? 3) What is the impact on patient outcomes as a result of adopting the technology? 4) What is the return on investment to the organization? These issues represent challenging areas for the researcher, clinician, manager, and policy maker. New techniques from the business and outcomes research arenas allow for the development of quantitative and qualitative models to facilitate answering these questions. By integrating business and clinical considerations, these models can impact policy at two levels: 1) by identifying optimal capital expenditure decisions for individual healthcare organizations, it can provide a significant competitive advantage for an organization; and 2) by identifying optimal health policies related to technology at a national and international health level, it can impact the healthcare systems and patient outcomes in a favorable manner.
引用
收藏
页码:N190 / N195
页数:6
相关论文
共 25 条
[1]  
Christensen CM, 2000, HARVARD BUS REV, V78, P102
[2]  
DAVIES LM, 1998, ANN M INT SOC TECHN, V14, P65
[3]   EVALUATING QUALITY OF MEDICAL CARE [J].
DONABEDIAN, A .
MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1966, 44 (03) :166-206
[4]   An economic framework for evaluating a multileaf collimator [J].
Dunscombe, P ;
Roberts, G .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (01) :242-250
[5]  
FELDSTEIN PJ, 1995, HLTH CARE EC
[6]   THE DISTINCTION BETWEEN COST AND CHARGES [J].
FINKLER, SA .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (01) :102-109
[7]  
Finkler SA., 1994, ESSENTIALS COST ACCO
[8]  
HUMMEL JM, 1999, ANN M INT SOC TECHN, V15, P133
[9]   APACHE - ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION - A PHYSIOLOGICALLY BASED CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
ZIMMERMAN, JE ;
WAGNER, DP ;
DRAPER, EA ;
LAWRENCE, DE .
CRITICAL CARE MEDICINE, 1981, 9 (08) :591-597
[10]   AN ANALYSIS OF THE COST-EFFECTIVENESS OF THE IMPLANTABLE DEFIBRILLATOR [J].
KUPPERMANN, M ;
LUCE, BR ;
MCGOVERN, B ;
PODRID, PJ ;
BIGGER, JT ;
RUSKIN, JN .
CIRCULATION, 1990, 81 (01) :91-100